Only One-Quarter of Adults Who Needed Opioid Use Disorder Meds in 2022 Received Them
By Elana Gotkine HealthDay Reporter
THURSDAY, June 27, 2024 -- Only one-quarter of adults who needed opioid use disorder (OUD) treatment in 2022 received medications for OUD, according to research published in the June 27 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Deborah Dowell, M.D., from the CDC in Atlanta, and colleagues characterized U.S. adult populations who needed OUD treatment, received any OUD treatment, and received medications for OUD using data from the 2022 National Survey on Drug Use and Health.
The researchers found that 3.7 percent of U.S. adults aged ≥18 years needed OUD treatment in 2022. Only 25.1 percent of these received medications for OUD. Most adults who needed OUD treatment did not perceive that they needed it or they received OUD treatment without medications (42.7 and 30.0 percent, respectively). A higher percentage of non-Hispanic White adults received any OUD treatment compared with non-Hispanic Black or African American and Hispanic or Latino adults. Compared with women, and younger or older adults, higher percentages of men and adults aged 35 to 49 years received medications for OUD.
"Expanded communication about effectiveness of medications for OUD is needed to reduce nonfatal and fatal overdoses," the authors write. "Increasing awareness among persons who use drugs and their families, friends, and other contacts that medications for OUD are effective is critical."
One author disclosed ties to General Electric, 3M, and Pfizer.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted June 2024
Read this next
Hospital Addiction Consultation Service Aids Opioid Use Disorder
WEDNESDAY, April 16, 2025 -- A hospital-based addiction consultation service can improve receipt of evidence-based treatment for people with opioid use disorder (OUD), according...
Stimulant Involvement in Opioid OD Death Higher for Those in Physically Demanding Jobs
TUESDAY, April 1, 2025 -- A higher percentage of individuals who have psychostimulant involvement in synthetic opioid overdose deaths tend to work in physically demanding...
Evidence Supports Continuing Buprenorphine for Acute Pain in Those With Opioid Use Disorder
MONDAY, March 31, 2025 -- For patients with opioid use disorder (OUD), evidence supports continuation of buprenorphine during episodes of acute pain, but overall evidence for pain...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.